NCT03022617View on ClinicalTrials.gov

A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 1, 2020

Study Completion Date

September 29, 2022

Conditions
Psoriatic NailPsoriasis VulgarisPsoriasis
Interventions
DRUG

Apremilast

Trial Locations (1)

35249

The Kirklin Clinic, Birmingham

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

University of Alabama at Birmingham

OTHER